US OptionsDetailed Quotes
STOK240816C12500
- 2.45
- 0.000.00%
15min DelayClose Jul 23 15:58 ET
0.00High0.00Low
2.45Open2.45Pre Close0 Volume19 Open Interest12.50Strike Price0.00Turnover162.66%IV2.54%PremiumAug 16, 2024Expiry Date2.08Intrinsic Value100Multiplier23DDays to Expiry0.37Extrinsic Value100Contract SizeAmericanOptions Type0.7210Delta0.0552Gamma4.23Leverage Ratio-0.0440Theta0.0046Rho3.05Eff Leverage0.0126Vega
Stoke Therapeutics Stock Discussion
Sign in to post a comment
$Stoke Therapeutics(STOK.US$ Stoke Therapeutics Prices Upsized $125M Public Offering Of 5,555,557 Common Shares At $13.50/Share
1
35
$Stoke Therapeutics(STOK.US$ BUYERS MAKE 💰💰💰💰🤩🤩💰💰💰 SELL ALL AND NEVER BUY BACK NHAO NHAO 😍😍😍
$Stoke Therapeutics(STOK.US$ im liking a lot! i just wish they woulda attached a darn price to that offering! I mean 18 dollars great! WooHoo even! But if it ends up being 7/8! look out below! Hehehe
1
4
$Stoke Therapeutics(STOK.US$ AH went green after company announces stock offering. offering must be higher than current price. solid company here. PT 15-20 IMO
13
$Stoke Therapeutics(STOK.US$ Wow! So far it hasnt done the typical im dopping 25/40% when the offering comes out! Color me impressed! hehehe
4
7
$Stoke Therapeutics(STOK.US$ Stoke Therapeutics Announces Proposed Public Offering Of Up To $75M Of Common Stock
Stoke Therapeutics: A Glimpse into the Future of RNA-Based Medicine.
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
$Stoke Therapeutics(STOK.US$ 20 possible 👀 low float therapeutics
9
1
No comment yet
Jaguar8 : Oh wow
Jaguar8 : Good morning brother!
TrytosaveabitOP Jaguar8: Good morning my man!
TrytosaveabitOP Jaguar8: I was thinking it was going to be like 8/9 dollars! Hehehe
Jaguar8 : Only had 1.5hrs sleep
View more comments...